Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 7/20 | 0.79 |
| ▸ | APAF1 | O14727 | 1/20 | 0.71 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.71 |
| ▸ | RAD52 | P43351 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | APEX1 | P27695 | 3/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | ACHE | P22303 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4303043 | 1.00 | DNM1 (0.79) | DNM1APAF1HSP90AA1RAD52MEN1 | |
| SCHEMBL3151214 | 1.00 | DNM1 (0.79) | DNM1APAF1HSP90AA1RAD52MEN1 | |
| SCHEMBL18604166 | 1.00 | DNM1 (0.79) | DNM1APAF1HSP90AA1RAD52MEN1 | |
| SCHEMBL1072780 | 1.00 | DNM1 (0.79) | DNM1APAF1HSP90AA1RAD52MEN1 | |
| SCHEMBL1071639 | 1.00 | DNM1 (0.79) | DNM1APAF1HSP90AA1RAD52MEN1 | |
| Cetrimonium SCHEMBL1339521 | 1.00 | DNM1 (0.79) | DNM1APAF1HSP90AA1RAD52MEN1 | |
| SCHEMBL18604130 | 1.00 | DNM1 (0.79) | DNM1APAF1HSP90AA1RAD52MEN1 | |
| SCHEMBL2150378 | 1.00 | DNM1 (0.79) | DNM1APAF1HSP90AA1RAD52MEN1 | |
| SCHEMBL18604067 | 1.00 | DNM1 (0.79) | DNM1APAF1HSP90AA1RAD52MEN1 | |
| SCHEMBL4302452 | 1.00 | DNM1 (0.79) | DNM1APAF1HSP90AA1RAD52MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8411347-B2 | Composition comprising photochromic dyes in an ionic solvent | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2013-04-02 | — | — | US | claimed |
| US-20110013252-A1 | COMPOSITION COMPRISING PHOTOCHROMIC DYES IN AN IONIC SOLVENT | Essilor International (compagnie Generale D'optiqu e (FR) | 2011-01-20 | — | — | US | claimed |
| US-20230374230-A1 | CROSSLINKED GEL FORMULATION | ESSILOR INTERNATIONAL (FR) | 2023-11-23 | — | — | US | disclosed |
| CN-116761848-A | Crosslinked gel formulations | 依视路国际公司 | 2023-09-15 | — | — | CN | disclosed |
| WO-2022078935-A1 | CROSSLINKED GEL FORMULATION | ESSILOR INTERNATIONAL (FR) | 2022-04-21 | — | — | WO | disclosed |
| EP-3985046-A1 | CROSSLINKED GEL FORMULATION | ESSILOR INTERNATIONAL (FR) | 2022-04-20 | — | — | EP | disclosed |
| EP-3300150-B1 | OXYGEN REDUCTION CATALYST, METHOD FOR PRODUCING THE SAME, AND POLYMER ELECTROLYTE FUEL CELL | SHOWA DENKO KK (JP) | 2020-02-19 | — | — | EP | disclosed |
| CN-105932305-B | Oxygen reduction catalyst, method for producing same, and solid polymer fuel cell | 昭和电工株式会社 | 2019-12-27 | — | — | CN | disclosed |
| US-10465303-B2 | Producing system of reduction product | KABUSHIKI KAISHA TOSHIBA (JP) | 2019-11-05 | — | — | US | disclosed |
| EP-2665119-B1 | METHOD FOR PRODUCING FUEL CELL ELECTRODE CATALYST, FUEL CELL ELECTRODE CATALYST, AND USES THEREOF | SHOWA DENKO KK (JP) | 2018-10-24 | — | — | EP | disclosed |
| EP-2665118-B1 | METHOD FOR PRODUCING FUEL CELL ELECTRODE CATALYST, FUEL CELL ELECTRODE CATALYST, AND APPLICATION THEREOF | SHOWA DENKO KK (JP) | 2018-04-11 | — | — | EP | disclosed |
| EP-1797953-B1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2011-01-05 | — | — | EP | disclosed |
| CN-1988955-B | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL CO | 2010-09-29 | — | — | CN | disclosed |
| EP-1975147-A1 | TETRAFLUOROTOLUENE COMPOUND, METHOD FOR PRODUCING SAME AND USE THEREOF | Sumitomo Chemical Company, Limited (JP) | 2008-10-01 | — | — | EP | disclosed |
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-03-13 | — | — | US | disclosed |
| US-7276622-B2 | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-02 | — | — | US | disclosed |
| CN-1988955-A | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL CO (JP) | 2007-06-27 | — | — | CN | disclosed |
| EP-1797953-A1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2007-06-20 | — | — | EP | disclosed |
| US-20060173221-A1 | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-08-03 | — | — | US | disclosed |
| EP-1609777-A1 | METHOD FOR PRODUCING OXYGEN-CONTAINING COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2005-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | AOC2, AOX1, CAT | DNM1 4076/4885APAF1 2171/4885HSP90AA1 903/4885 |
| US-20060173221-A1 | Method for producing oxygen-containing compound | GPX4, DUOX2, SCO2 | DNM1 3184/4885APAF1 969/4885HSP90AA1 2796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.